Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients.

Abstract

Cystic fibrosis (CF) is associated with increased rates of morbidity and mortality due to fungal and bacterial colonisation of the airways or respiratory infections. The prevalence of fungi in Iranian CF population has been underestimated. Therefore, the current study was conducted to define the frequency of fungi in respiratory specimens obtained from Iranian CF patients based on conventional and molecular assays. Furthermore, in vitro antifungal susceptibility testing was performed on the obtained isolates according to the guidelines from the Clinical and Laboratory Standards Institute. A cohort of 42 CF patients, including 29 males and 13 females, were categorised according to the referenced diagnostic criteria. Candida albicans (n=24, 80%), C.dubliniensis (n=2, 6.6%), C.parapsilosis (n=2, 6.6%), C.tropicalis (n=1, 3.3%), C.glabrata (n=1, 3.3%) and Meyerozyma caribbica (n=1, 3.3%) were isolated from 73.8% of the CF patients. Aspergillus terreus (n=3, 42.8%) was identified as the most common Aspergillus species, followed by A.fumigatus (n=2, 28.5%), A.oryzae (n=1, 14.2%) and A.flavus (n=1, 14.2%). Bacterial and fungal co-colonisation was detected in 7 (16.6%) and 22 (52.3%) samples that were positive for Aspergillus and Candida species, respectively. However, Scedosporium species and Exophiala dermatitidis never were detected. In terms of geometric mean (GM) minimum inhibitory concentrations (MICs), posaconazole (0.018μg/mL) and caspofungin (0.083μg/mL) exhibited the highest antifungal activities against all Candida species. In addition, posaconazole exhibited the lowest MIC range (0.008-0.063μg/mL) against all Aspergillus species, followed by caspofungin (0.016-0.125μg/mL) and voriconazole (0.125-0.25μg/mL). To conclude, it is essential to adopt a consistent method for the implementation of primary diagnosis and determination of treatment regimen for the CF patients. However, further studies are still needed to better define the epidemiology of fungal organisms in CF patients from the Middle East and the clinical significance of their isolation.